Index Performance
Overview
Description
The coming years will welcome a new breed of historically important, publicly listed healthcare technology companies that more closely resemble the tech mega-caps of today, with platform-based innovation, highly scalable business models, network effects, high impact, and high value creation. Technologies such as teleoperated devices, wearable sensors, and machine learning and artificial intelligence are arming patients and healthcare providers with tools to make better and quicker clinical decisions. The intersection of healthcare and technology has the potential to transform everything from how patients interact with care providers, to how diagnostic data is obtained and analyzed, from the ways interventions are recommended to the ways outcomes are measured. Developed by Lux Capital, the Lux Health + Tech Index™ recognizes the life-changing power of healthcare + technology.
Full methodology- TickerLUXHT
- Inception Date04/27/2021
- WeightingEqual
- # of holdings43
What's inside?
Holdings
All holdings as of July 18, 2025
| Hims & Hers Health, Inc. (HIMS) | 6.53% | $11.28B | 110.67% | 62.74% | 3.94 |
| GRAIL, Inc. (GRAL) | 6.20% | $1.27B | 19.15% | -73.92% | 2.03 |
| iRhythm Technologies, Inc. (IRTC) | 4.97% | $4.35B | 20.27% | 68.83% | 5.69 |
| Guardant Health, Inc. (GH) | 4.79% | $5.76B | 20.76% | 63.28% | 7.60 |
| Adaptive Biotechnologies Corp. (ADPT) | 4.34% | $1.58B | 25.24% | 61.66% | 5.99 |
| Veeva Systems, Inc. (VEEV) | 3.17% | $46.13B | 16.71% | 76.73% | 11.51 |
| Doximity, Inc. (DOCS) | 3.14% | $11.27B | 19.98% | 90.20% | 18.89 |
| Progyny, Inc. (PGNY) | 3.11% | $1.89B | 16.53% | 23.39% | 1.46 |
| Waystar Holding Corp. (WAY) | 3.11% | $6.35B | 14.08% | 54.48% | 7.93 |
| Insulet Corp. (PODD) | 2.83% | $20.00B | 28.82% | 72.79% | 9.04 |
| DexCom, Inc. (DXCM) | 2.82% | $32.89B | 12.49% | 56.85% | 6.68 |
| Schrödinger, Inc. (SDGR) | 2.81% | $1.57B | 62.72% | 52.26% | 4.54 |
| Tempus AI, Inc. (TEM) | 2.65% | $10.56B | 75.38% | 59.10% | 11.03 |
| Masimo Corp. (MASI) | 2.55% | $8.38B | -24.51% | 62.90% | 4.75 |
| ResMed, Inc. (RMD) | 2.55% | $37.82B | 7.92% | 58.49% | 6.54 |
| Intuitive Surgical, Inc. (ISRG) | 2.47% | $185.88B | 19.19% | 64.67% | 20.21 |
| Natera, Inc. (NTRA) | 2.45% | $18.97B | 36.46% | 63.12% | 9.97 |
| Teladoc Health, Inc. (TDOC) | 2.05% | $1.41B | -2.59% | 54.76% | 0.70 |
| Definitive Healthcare Corp. (DH) | 2.04% | $561.94M | -6.76% | 59.52% | 1.69 |
| Fulgent Genetics, Inc. (FLGT) | 1.97% | $541.29M | 13.92% | 35.88% | 0.70 |
| Twist Bioscience Corp. (TWST) | 1.87% | $2.11B | 23.23% | 49.60% | 6.23 |
| PROCEPT BioRobotics Corp. (PRCT) | 1.84% | $3.23B | 55.28% | 63.85% | 11.89 |
| Pacific Biosciences of California, Inc. (PACB) | 1.83% | $411.12M | -4.27% | -978.15% | 4.63 |
| Hologic, Inc. (HOLX) | 1.83% | $14.26B | -1.23% | 55.40% | 3.66 |
| Globus Medical, Inc. (GMED) | 1.83% | $7.63B | -1.41% | 62.52% | 3.93 |
| Align Technology, Inc. (ALGN) | 1.82% | $13.83B | -1.82% | 69.93% | 2.75 |
| EXACT Sciences Corp. (EXAS) | 1.71% | $9.52B | 10.86% | 70.82% | 3.48 |
| Clover Health Investments Corp. (CLOV) | 1.68% | $1.50B | 33.45% | N/A | 1.20 |
| Veracyte, Inc. (VCYT) | 1.64% | $1.84B | 18.20% | 67.61% | 4.61 |
| IQVIA Holdings, Inc. (IQV) | 1.61% | $27.79B | 2.43% | 27.02% | 2.83 |
| Illumina, Inc. (ILMN) | 1.57% | $15.22B | -3.25% | 65.80% | 3.25 |
| Oscar Health, Inc. (OSCR) | 1.54% | $3.42B | 42.20% | N/A | 0.43 |
| GoodRx Holdings, Inc. (GDRX) | 1.54% | $1.67B | 2.57% | 83.11% | 2.40 |
| Cytek Biosciences, Inc. (CTKB) | 1.42% | $396.44M | -7.59% | 48.62% | 1.40 |
| 10X Genomics, Inc. (TXG) | 1.41% | $1.52B | 9.84% | 70.64% | 1.16 |
| Lifestance Health Group, Inc. (LFST) | 1.40% | $1.64B | 10.83% | 28.84% | 2.30 |
| Inspire Medical Systems, Inc. (INSP) | 1.36% | $3.74B | 22.75% | 84.75% | 5.35 |
| Castle Biosciences, Inc. (CSTL) | 1.30% | $477.55M | 20.57% | 48.58% | 0.93 |
| Health Catalyst, Inc. (HCAT) | 1.09% | $254.04M | 6.28% | 32.12% | 1.19 |
| NeoGenomics, Inc. (NEO) | 1.03% | $803.05M | 7.55% | 41.54% | 2.16 |
| CareDx, Inc. (CDNA) | 0.89% | $663.43M | 17.54% | 65.70% | 2.25 |
| Tandem Diabetes Care, Inc. (TNDM) | 0.82% | $983.79M | 22.30% | 50.51% | 1.42 |
| Myriad Genetics, Inc. (MYGN) | 0.39% | $412.03M | -3.12% | 68.50% | 1.05 |